ME Projected Dividend Yield
Cl A/23andMe Holding Co ( NASDAQ : ME )23andMe Holding Co. is a genetics-led consumer healthcare and biopharmaceutical company. Co. operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. 21 YEAR PERFORMANCE RESULTS |
ME Dividend History Detail ME Dividend News ME Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |